List of insiders holdings for Galera Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Schneid Yair 10% Owner |
2024-05-16 10:26:17 | 10,823,610 0 |
10,823,610 | Form 13G |
| 2 | Soffer Rochel ALPHA PHARMA Investments LLC 10% Owner |
2024-05-16 10:26:45 | 3,178,137 2,750,000 |
5,928,137 | Form 3 |
| 3 | New Enterprise Associates 14 L.P. Sonsini Peter W. KERINS PATRICK J NEA Partners 14 L.P. NEA 14 GP LTD BARRIS PETER J BASKETT FOREST Florence Anthony A. Jr. MOTT DAVID M SANDELL SCOTT D 10% Owner |
2020-02-13 10:50:02 | 4,358,042 0 |
4,358,042 | Form 13G |
| 4 | Blackstone Clarus GP L.P. Blackstone Clarus GP L.L.C. Blackstone Holdings II L.P. Blackstone Holdings I/II GP L.L.C. Blackstone Group Inc Blackstone Group Management L.L.C. SCHWARZMAN STEPHEN A 10% Owner |
2023-12-04 16:32:02 | 2,289,605 0 |
2,289,605 | Form 13D |
| 5 | Novo Holdings A/S 10% Owner |
2023-06-28 16:19:56 | 2,100,000 0 |
2,100,000 | Form 13G |
| 6 | Novartis Bioventures Ltd NOVARTIS AG Former 10% Owner |
2022-02-11 16:30:53 | 476,085 0 |
476,085 | Form 13G |
| 7 | Sorensen Mel President and CEO |
2024-08-20 16:45:02 | 265,029 0 |
265,029 | Form 4 |
| 8 | Keene Jeffrey 10% Owner |
2019-11-06 17:27:59 | 172,238 0 |
172,238 | Form 3 |
| 9 | Stacey Jennifer Evans See Remarks |
2023-02-28 18:56:05 | 135,000 0 |
135,000 | Form 4 |
| 10 | Beardsley Robert A Chief Operating Officer |
2023-02-28 19:06:09 | 135,000 0 |
135,000 | Form 4 |
| 11 | Clarus IV-A L.P. Clarus IV-B L.P. Clarus IV-C L.P. Clarus IV-D L.P. Clarus IV GP L.P. 10% Owner |
2019-11-14 17:00:59 | 0 130,444 |
130,444 | Form 4 |
| 12 | FRIEDMAN MICHAEL R. Director |
2025-02-26 16:52:57 | 96,000 0 |
96,000 | Form 4 |
| 13 | CHANG NANCY T Director 10% Owner |
2025-02-26 16:46:22 | 96,000 0 |
96,000 | Form 4 |
| 14 | Fratamico Arthur Chief Business Officer |
2021-01-28 16:05:09 | 75,000 0 |
75,000 | Form 4 |
| 15 | HOLMLUND JON T Chief Medical Officer |
2022-03-02 16:05:46 | 75,000 0 |
75,000 | Form 4 |
| 16 | Matthes Catherine L. 10% Owner |
2019-11-06 17:24:24 | 8,503 66,184 |
74,687 | Form 3 |
| 17 | Riley Dennis Chief Scientific Officer |
2020-02-04 18:00:43 | 74,435 0 |
74,435 | Form 4 |
| 18 | POWELL MICHAEL Director |
2023-06-16 16:15:35 | 64,000 0 |
64,000 | Form 4 |
| 19 | Buckler Regina A. 10% Owner |
2019-11-06 17:28:54 | 62,254 0 |
62,254 | Form 3 |
| 20 | Brill Jeffrey 10% Owner |
2019-11-06 17:31:51 | 62,137 0 |
62,137 | Form 3 |
| 21 | Wood Brian 10% Owner |
2019-11-06 17:32:34 | 62,137 0 |
62,137 | Form 3 |
| 22 | Schall Otto 10% Owner |
2019-11-06 17:20:10 | 55,137 0 |
55,137 | Form 3 |
| 23 | Kennedy Eugene P. Chief Medical Officer |
2023-02-28 18:57:34 | 55,000 0 |
55,000 | Form 4 |
| 24 | Sussman Joel F. Chief Accounting Officer |
2021-01-28 16:05:16 | 50,000 0 |
50,000 | Form 4 |
| 25 | LOKAY KEVIN G Director |
2025-02-26 16:57:11 | 48,000 0 |
48,000 | Form 4 |
| 26 | Alleva Lawrence M Director |
2025-02-26 16:43:38 | 48,000 0 |
48,000 | Form 4 |
| 27 | Ross Stephen A 10% Owner |
2019-11-06 17:21:58 | 46,622 0 |
46,622 | Form 3 |
| 28 | West Linda Director |
2023-07-05 16:11:02 | 23,382 0 |
23,382 | Form 4 |
| 29 | Fuller Jason Director |
2019-11-08 19:49:13 | 19,776 0 |
19,776 | Form 4 |
| 30 | Bachleda Mark Chief Commercial Officer |
2023-03-20 16:05:17 | 11,000 0 |
11,000 | Form 4 |
| 31 | Degnan Chris Chief Financial Officer |
2023-03-14 08:30:09 | 10,000 0 |
10,000 | Form 4 |
| 32 | Altamont Pharmaceutical Holdings LLC Pearson Mark E. 10% Owner |
2024-04-03 08:08:38 | 0 0 |
0 | Form 13G |
| 33 | Cunningham Emmett Director |
2023-06-16 16:15:10 | 0 0 |
0 | Form 4 |
| 34 | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. POWELL MICHAEL HEALY JAMES Mehra Anand 10% Owner |
2024-02-20 18:57:58 | 0 0 |
0 | Form 13D |